BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9196160)

  • 1. Sexual dysfunction in nonseminoma testicular cancer patients is related to chemotherapy-induced angiopathy.
    van Basten JP; Hoekstra HJ; van Driel MF; Koops HS; Droste JH; Jonker-Pool G; van de Wiel HB; Sleijfer DT
    J Clin Oncol; 1997 Jun; 15(6):2442-8. PubMed ID: 9196160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.
    Horwich A; Sleijfer DT; Fosså SD; Kaye SB; Oliver RT; Cullen MH; Mead GM; de Wit R; de Mulder PH; Dearnaley DP; Cook PA; Sylvester RJ; Stenning SP
    J Clin Oncol; 1997 May; 15(5):1844-52. PubMed ID: 9164194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group.
    de Wit R; Stoter G; Kaye SB; Sleijfer DT; Jones WG; ten Bokkel Huinink WW; Rea LA; Collette L; Sylvester R
    J Clin Oncol; 1997 May; 15(5):1837-43. PubMed ID: 9164193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexual functioning after treatment for testicular cancer: comparison of treatment modalities.
    Jonker-Pool G; van Basten JP; Hoekstra HJ; van Driel MF; Sleijfer DT; Koops HS; van de Wiel HB
    Cancer; 1997 Aug; 80(3):454-64. PubMed ID: 9241079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erectile dysfunction with chemotherapy.
    van Basten JP; van Driel MF; Hoekstra HJ; Sleijfer DT
    Lancet; 2000 Jul; 356(9224):169. PubMed ID: 10963279
    [No Abstract]   [Full Text] [Related]  

  • 6. Sexual Function in a Nationwide Cohort of 2,260 Survivors of Testicular Cancer after 17 Years of Followup.
    Bandak M; Lauritsen J; Johansen C; Kreiberg M; Skøtt JW; Agerbaek M; Holm NV; Daugaard G
    J Urol; 2018 Oct; 200(4):794-800. PubMed ID: 29730199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study.
    Kaye SB; Mead GM; Fossa S; Cullen M; deWit R; Bodrogi I; van Groeningen C; Sylvester R; Collette L; Stenning S; De Prijck L; Lallemand E; deMulder P
    J Clin Oncol; 1998 Feb; 16(2):692-701. PubMed ID: 9469359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Objective and subjective effects of treatment for testicular cancer on sexual function.
    van Basten JP; van Driel MF; Hoekstra HJ; Sleijfer DT; van de Wiel HB; Droste JH; Schraffordt Koops H; Mensink HJ
    BJU Int; 1999 Oct; 84(6):671-8. PubMed ID: 10510114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexual functioning after multimodality treatment for disseminated nonseminomatous testicular germ cell tumor.
    van Basten JP; Jonker-Pool G; van Driel MF; Sleijfer DT; Droste JH; van de Wiel HB; Schraffordt Koops H; Molenaar WM; Hoekstra HJ
    J Urol; 1997 Oct; 158(4):1411-6. PubMed ID: 9302133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin.
    Stoter G; Koopman A; Vendrik CP; Struyvenberg A; Sleyfer DT; Willemse PH; Schraffordt Koops H; van Oosterom AT; ten Bokkel Huinink WW; Pinedo HM
    J Clin Oncol; 1989 Aug; 7(8):1099-104. PubMed ID: 2474060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors.
    Christian JA; Huddart RA; Norman A; Mason M; Fossa S; Aass N; Nicholl EJ; Dearnaley DP; Horwich A
    J Clin Oncol; 2003 Mar; 21(5):871-7. PubMed ID: 12610187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
    Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
    J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fertility and sexual function following orchiectomy and 2 cycles of chemotherapy for stage I high risk nonseminomatous germ cell cancer.
    Böhlen D; Burkhard FC; Mills R; Sonntag RW; Studer UE
    J Urol; 2001 Feb; 165(2):441-4. PubMed ID: 11176393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial.
    Culine S; Theodore C; Terrier-Lacombe MJ; Droz JP
    J Urol; 1997 Mar; 157(3):855-8; discussion 858-9. PubMed ID: 9072585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term complications of chemotherapy for germ cell tumours.
    Chaudhary UB; Haldas JR
    Drugs; 2003; 63(15):1565-77. PubMed ID: 12887263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raynaud's phenomenon: a common toxicity after combination chemotherapy for testicular cancer.
    Vogelzang NJ; Bosl GJ; Johnson K; Kennedy BJ
    Ann Intern Med; 1981 Sep; 95(3):288-92. PubMed ID: 6168223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors.
    Motzer RJ; Sheinfeld J; Mazumdar M; Bajorin DF; Bosl GJ; Herr H; Lyn P; Vlamis V
    J Clin Oncol; 1995 Nov; 13(11):2700-4. PubMed ID: 7595727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of testicular cancer: 10-year experience.
    Ondrus D; Hornák M; Matoska J; Kausitz J; Belan V; Cársky S
    Neoplasma; 1993; 40(4):247-53. PubMed ID: 7505886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin.
    Vogelzang NJ; Torkelson JL; Kennedy BJ
    Cancer; 1985 Dec; 56(12):2765-70. PubMed ID: 2413982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.